Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.468 USD | +1.92% | +2.27% | -0.16% |
03-13 | Transcript : Spero Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 | |
03-13 | Spero Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.16% | 77.61M | |
-2.70% | 102B | |
+1.89% | 96.29B | |
+1.83% | 22.18B | |
-15.46% | 21.2B | |
-8.68% | 18.31B | |
-38.74% | 17.38B | |
-14.06% | 16.36B | |
+5.65% | 13.97B | |
+32.94% | 12.17B |
- Stock Market
- Equities
- SPRO Stock
- News Spero Therapeutics, Inc.
- Earnings Flash (SPRO) SPERO THERAPEUTICS Posts Q3 Revenue $2M